Beta carotene
- Generic Name
- Beta carotene
- Brand Names
- Pregvit
- Drug Type
- Small Molecule
- Chemical Formula
- C40H56
- CAS Number
- 7235-40-7
- Unique Ingredient Identifier
- 01YAE03M7J
- Background
Beta-carotene, with the molecular formula C40H56, belongs to the group of carotenoids consisting of isoprene units. The presence of long chains of conjugated double bonds donates beta-carotene with specific colors. It is the most abundant form of carotenoid and it is a precursor of the vitamin A. Beta-carotene is composed of two retinyl groups. It is an anti...
- Indication
Beta-carotene is FDA approved to be used as a nutrient supplement and to be even added in infant formula as a source of vitamin A. It is also approved to be used as a color additive for food products, drugs (with the label of "only as a color additive") and cosmetics.
...
- Associated Conditions
- Deficiency, Vitamin A
- Associated Therapies
- Nutritional supplementation
The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β
- Conditions
- Interventions
- First Posted Date
- 2016-12-29
- Last Posted Date
- 2017-11-21
- Lead Sponsor
- Indonesia University
- Target Recruit Count
- 56
- Registration Number
- NCT03005496
Arterial Disease Multifactorial Intervention Trial (ADMIT)
- Conditions
Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT00000541
Randomized Trial of Beta-Carotene and Macular Degeneration
- Conditions
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000152
Randomized Trials of Vitamin Supplements and Eye Disease
- Conditions
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000161
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.